Johnson & Johnson, drug distributors enter $26B opioid settlement

Narcotic drugs (opioids)
Katy L. Pack/iStock via Getty Images

  • Johnson & Johnson (JNJ +0.6%) along with three major U.S. drug distributors have reached a $26B settlement with a group of state attorneys general over claims that they helped fuel the nation’s opioid crisis.

Recommended For You

Comments (39)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.